Association between duration of immunotherapy and overall survival in advanced nonsmall-cell lung cancer

被引：0
|
作者：
Sun, Lova
Bleiberg, Benjamin Aaron
Hwang, Wei-Ting
Marmarelis, Melina Elpi
Langer, Corey J.
Singh, Aditi Puri
Cohen, Roger B.
Mamtani, Ronac
Aggarwal, Charu
机构：
[1] Univ Penn, Philadelphia, PA USA
[2] Univ Penn Hlth Syst, Philadelphia, PA USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9101
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunotherapy for nonsmall-cell lung cancer
    Belalcazar, Astrid
    Raez, Luis E.
    Santos, Edgardo S.
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2012, 5 (02) : 90 - 93
  • [2] Immunotherapy for nonsmall-cell lung cancer
    Astrid Belalcazar
    Luis E. Raez
    Edgardo S. Santos
    [J]. memo - Magazine of European Medical Oncology, 2012, 5 (2) : 90 - 93
  • [3] Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer
    Sun, Lova
    Bleiberg, Benjamin
    Hwang, Wei-Ting
    Marmarelis, Melina E.
    Langer, Corey J.
    Singh, Aditi
    Cohen, Roger B.
    Mamtani, Ronac
    Aggarwal, Charu
    [J]. JAMA ONCOLOGY, 2023, 9 (08) : 1075 - 1082
  • [4] Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?
    Cistaro, Angelina
    Quartuccio, Natale
    Mojtahedi, Alireza
    Fania, Piercarlo
    Filosso, Pier Luigi
    Cucinotta, Mariapaola
    Campenni, Alfredo
    Ficola, Umberto
    Baldari, Sergio
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,
  • [5] The Association Between Modified AlbuminBilirubin (mALBI) and Survival in Advanced Nonsmall Cell Lung Cancer Patients Treated With Immunotherapy
    Xu, Xiaoya
    Shi, Xiangru
    Zhou, Dingjie
    Cao, Dedong
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [6] Bevacizumab extends survival in nonsmall-cell lung cancer
    不详
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (01) : 5 - 6
  • [7] Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world
    Shokoohi, Aria
    Al-Hashami, Zamzam
    Moore, Sara
    Pender, Alexandra
    Wong, Selina K.
    Wang, Ying
    Leung, Bonnie
    Wu, Jonn
    Ho, Cheryl
    [J]. CANCER MEDICINE, 2022, 11 (01): : 86 - 93
  • [8] Combined modality treatment for locally advanced nonsmall-cell lung cancer
    Kelly, K
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (04) : 349 - 356
  • [9] Immunotherapy combinations in advanced nonsmall cell lung cancer
    Pirker, Robert
    [J]. CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 73 - 79
  • [10] Maintenance therapy: a new treatment paradigm in advanced nonsmall-cell lung cancer
    Gridelli, Cesare
    [J]. CURRENT OPINION IN ONCOLOGY, 2013, 25 (02) : 105 - 106
12345